Month: September 2022

Sep 11 2022

Uncategorized

Schizophrenia and Bipolar Disorder May Be Detectable Years Before Illnesses Begin

by Clinical Editor

No Comments

Researchers report bipolar depression and schizophrenia may be detectable several years before symptoms appear. A new study reports 50% of patients diagnosed with schizophrenia or bipolar disorder …

Sep 11 2022

Uncategorized

Jonathan had schizophrenia and died at 24. Now Tom Conroy is playing him on stage

by Clinical Editor

No Comments

The actor is wowing audiences as Jonathan Blain, the son at the heart of Anne Deveson’s bestselling memoir Tell Me I’m Here. He talks about preparing for such a difficult...

Sep 11 2022

Uncategorized

Karuna’s High Share Price Following Schizophrenia Data Gives Me Vertigo

by Clinical Editor

No Comments

Karuna Therapeutics could disrupt the Schizophrenia market with its differentiated drug candidate KarXT. Click here to read our analysis of KRTX stock.

Sep 11 2022

Uncategorized

Half of adults who develop schizophrenia had attended CAMHS services

by Clinical Editor

No Comments

Individuals who developed psychosis or bipolar disorder were more likely to have had an initial CAMHS diagnosis of depressive or other mood disorder and disruptive behaviour disorder …

Sep 11 2022

Uncategorized

Understanding the symptoms of schizophrenia

by Clinical Editor

No Comments

Schizophrenia is a mental health condition that usually appears in late adolescence or early adulthood. Its impact on speech, thinking, emotions, and other areas of life can affect a person’s...

Sep 10 2022

Uncategorized

Jonathan had schizophrenia and died at 24. Now Tom Conroy is playing him on stage

by Clinical Editor

No Comments

The actor is wowing audiences as Jonathan Blain, the son at the heart of Anne Deveson’s bestselling memoir Tell Me I’m Here. He talks about preparing for such a difficult...

Sep 10 2022

Uncategorized

Karuna’s High Share Price Following Schizophrenia Data Gives Me Vertigo

by Clinical Editor

No Comments

Karuna Therapeutics could disrupt the Schizophrenia market with its differentiated drug candidate KarXT. Click here to read our analysis of KRTX stock.

Sep 10 2022

Uncategorized

Schizophrenia and Bipolar Disorder May Be Detectable Years Before Illnesses Begin

by Clinical Editor

No Comments

Researchers report bipolar depression and schizophrenia may be detectable several years before symptoms appear. A new study reports 50% of patients diagnosed with schizophrenia or bipolar disorder …

Sep 10 2022

Uncategorized

Motivation-pleasure and expression are two latent factors underlying negative symptoms of schizophrenia patients

by Clinical Editor

No Comments

Negative symptoms such as reduced ability to experience of pleasure, lack of motivation and diminished ability to express emotional responses for relevant social interaction are strongly correlated …

Sep 10 2022

Uncategorized

Half of adults who develop schizophrenia had attended CAMHS services

by Clinical Editor

No Comments

Individuals who developed psychosis or bipolar disorder were more likely to have had an initial CAMHS diagnosis of depressive or other mood disorder and disruptive behaviour disorder …